首页 > 最新文献

Journal of Radiotherapy in Practice最新文献

英文 中文
Wobbling nature of gamma passing rate as a function of calibration field sizes in patient-specific quality assurance 伽马通过率的摇摆特性是病人特定质量保证中校准场大小的函数
IF 0.4 Q4 Medicine Pub Date : 2024-01-11 DOI: 10.1017/S1460396923000444
Sathiya Raj, Venugopal Sundaram, H. Godson, Retna John
Abstract Purpose: This study aimed to investigate the influence of calibration field size on the gamma passing rate (GPR) in patient-specific quality assurance (PSQA). Methods: Two independent detectors, PTW OCTAVIUS 4D (4DOCT) and Arc Check, were utilised in volumetric modulated arc therapy plans for 26 patients (14 with Arc Check and 12 with 4DOCT). Plans were administered using Varian Unique machine (with 4DOCT) and Varian TrueBeam (with Arc Check), each employing different calibration factors (CFs): 4 × 4, 6 × 6, 8 × 8, 10 × 10, 12 × 12 and 15 × 15 cm2 field sizes. Gamma analysis was conducted with 2%2mm, 2%3mm and 3%3mm gamma criteria. Results: GPR exhibited variations across different CFs. GPR demonstrated an increasing trend below 10 × 10 cm² CFs, while it displayed a decreasing trend above 10 × 10 cm². Both detectors exhibited similar GPR patterns. The correlation between 4DOCT and Arc Check was strong in tighter criteria (2%2mm) with an R² value of 0·9957, moderate criteria (2%3mm) with an R² value of 0·9868, but reduced in liberal criteria (3%3mm) with an R² value of 0·4226. Conclusion: This study demonstrates that calibration field sizes significantly influence GPR in PSQA. This study recommends the plan specific calibration field must obtain to calibrate the QA devices for modulated plans.
摘要 目的:本研究旨在探讨校准场大小对患者特定质量保证(PSQA)中伽马通过率(GPR)的影响。方法:使用两台独立的检测器,PTW OCT 960 和 PTW OCT 960:在对 26 名患者(14 名使用 Arc Check,12 名使用 4DOCT)的容积调制弧治疗计划中使用了两个独立的探测器:PTW OCTAVIUS 4D (4DOCT) 和 Arc Check。计划使用瓦里安 Unique 设备(4DOCT)和瓦里安 TrueBeam(Arc Check)实施,每种设备都采用了不同的校准因子(CF):4 × 4、6 × 6、8 × 8、10 × 10、12 × 12 和 15 × 15 平方厘米的视野尺寸。伽马分析采用 2%2mm、2%3mm 和 3%3mm 伽马标准。结果:GPR 在不同的 CF 上表现出差异。10 × 10 平方厘米以下的 GPR 呈上升趋势,而 10 × 10 平方厘米以上的 GPR 呈下降趋势。两种检测器显示出相似的 GPR 模式。4DOCT 和 Arc Check 之间的相关性在严格标准(2%2mm)下很强,R² 值为 0-9957,在中等标准(2%3mm)下 R² 值为 0-9868,但在宽松标准(3%3mm)下有所降低,R² 值为 0-4226。结论本研究表明,校准区域的大小对 PSQA 中的 GPR 有显著影响。本研究建议,必须获得特定于规划的校准区域,以校准调制规划的质量保证设备。
{"title":"Wobbling nature of gamma passing rate as a function of calibration field sizes in patient-specific quality assurance","authors":"Sathiya Raj, Venugopal Sundaram, H. Godson, Retna John","doi":"10.1017/S1460396923000444","DOIUrl":"https://doi.org/10.1017/S1460396923000444","url":null,"abstract":"Abstract Purpose: This study aimed to investigate the influence of calibration field size on the gamma passing rate (GPR) in patient-specific quality assurance (PSQA). Methods: Two independent detectors, PTW OCTAVIUS 4D (4DOCT) and Arc Check, were utilised in volumetric modulated arc therapy plans for 26 patients (14 with Arc Check and 12 with 4DOCT). Plans were administered using Varian Unique machine (with 4DOCT) and Varian TrueBeam (with Arc Check), each employing different calibration factors (CFs): 4 × 4, 6 × 6, 8 × 8, 10 × 10, 12 × 12 and 15 × 15 cm2 field sizes. Gamma analysis was conducted with 2%2mm, 2%3mm and 3%3mm gamma criteria. Results: GPR exhibited variations across different CFs. GPR demonstrated an increasing trend below 10 × 10 cm² CFs, while it displayed a decreasing trend above 10 × 10 cm². Both detectors exhibited similar GPR patterns. The correlation between 4DOCT and Arc Check was strong in tighter criteria (2%2mm) with an R² value of 0·9957, moderate criteria (2%3mm) with an R² value of 0·9868, but reduced in liberal criteria (3%3mm) with an R² value of 0·4226. Conclusion: This study demonstrates that calibration field sizes significantly influence GPR in PSQA. This study recommends the plan specific calibration field must obtain to calibrate the QA devices for modulated plans.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary fragmentation and relative biological effectiveness (RBE) study using Bridge SOI microdosimeter: Monte Carlo simulation 使用桥式 SOI 微剂量计进行二次碎裂和相对生物效应 (RBE) 研究:蒙特卡罗模拟
IF 0.4 Q4 Medicine Pub Date : 2024-01-09 DOI: 10.1017/S1460396923000420
C. Ying, M. Arif Efendi, Susanna Guatelli, L. Tran, D. Bolst
Abstract Introduction: This work calculates the microdosimetric spectra and evaluates the relative biological effectiveness (RBE10) of oxygen and carbon ions using Monte Carlo simulation. This study presents a fast, reliable radiation field characterisation and accurate biological dose prediction tool in charged particle therapy for heavy-ion beams using the Bridge silicon-on-insulator (SOI) microdosimeter via Tool for Particle Simulation (TOPAS)-based simulations toolkit. Method: The study used the TOPAS simulation to model the Bridge SOI microdosimeter and study its response to carbon beams with an energy of 290 MeV/u and oxygen beams with an energy of 345 MeV/u. Dose-mean lineal energy values $(overline {{y_D});} $ and RBE10 values were evaluated using microdosimetric lineal energy spectra with the MKM model. Results and Conclusions: The results demonstrate that oxygen ion beams have an advantage for cancer treatment as they provide higher RBE10 values and occur at the same positions as the maximum physical dose (Bragg peak), compared to carbon ion beams. The study provides new understanding of RBE for carbon and oxygen ions, as well as the relationship between physical doses and RBE.
摘要 简介:这项研究利用蒙特卡罗模拟计算了氧离子和碳离子的微剂量谱,并评估了其相对生物效应(RBE10)。这项研究通过基于粒子模拟工具包(Tool for Particle Simulation,TOPAS)的 Bridge 硅绝缘体(SOI)微剂量计,为重离子束的带电粒子治疗提供了一种快速、可靠的辐射场表征和精确生物剂量预测工具。方法:研究使用 TOPAS 仿真对 Bridge SOI 微剂量计进行建模,并研究其对能量为 290 MeV/u 的碳束和能量为 345 MeV/u 的氧束的响应。利用 MKM 模型的微透射线能谱评估了剂量平均线能值 $(overline {{y_D});} $ 和 RBE10 值。结果与结论:结果表明,与碳离子束相比,氧离子束在治疗癌症方面具有优势,因为它们能提供更高的 RBE10 值,并且与最大物理剂量(布拉格峰)出现在相同的位置。这项研究使人们对碳离子和氧离子的 RBE 以及物理剂量与 RBE 之间的关系有了新的认识。
{"title":"Secondary fragmentation and relative biological effectiveness (RBE) study using Bridge SOI microdosimeter: Monte Carlo simulation","authors":"C. Ying, M. Arif Efendi, Susanna Guatelli, L. Tran, D. Bolst","doi":"10.1017/S1460396923000420","DOIUrl":"https://doi.org/10.1017/S1460396923000420","url":null,"abstract":"Abstract Introduction: This work calculates the microdosimetric spectra and evaluates the relative biological effectiveness (RBE10) of oxygen and carbon ions using Monte Carlo simulation. This study presents a fast, reliable radiation field characterisation and accurate biological dose prediction tool in charged particle therapy for heavy-ion beams using the Bridge silicon-on-insulator (SOI) microdosimeter via Tool for Particle Simulation (TOPAS)-based simulations toolkit. Method: The study used the TOPAS simulation to model the Bridge SOI microdosimeter and study its response to carbon beams with an energy of 290 MeV/u and oxygen beams with an energy of 345 MeV/u. Dose-mean lineal energy values \u0000$(overline {{y_D});} $\u0000 and RBE10 values were evaluated using microdosimetric lineal energy spectra with the MKM model. Results and Conclusions: The results demonstrate that oxygen ion beams have an advantage for cancer treatment as they provide higher RBE10 values and occur at the same positions as the maximum physical dose (Bragg peak), compared to carbon ion beams. The study provides new understanding of RBE for carbon and oxygen ions, as well as the relationship between physical doses and RBE.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139444107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study. 治疗头颈部放疗期间放射性皮炎的角蛋白外用乳膏:一项随机、开放标签试验研究。
IF 0.3 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-01-01 Epub Date: 2024-04-15 DOI: 10.1017/s1460396924000037
Ryan T Hughes, Beverly J Levine, Bart A Frizzell, Kathryn M Greven, Mercedes Porosnicu, Thomas W Lycan, Luke R Burnett, Karen M Winkfield

Introduction: Radiation dermatitis (RD) is a frequent toxicity during radiotherapy (RT) for head and neck cancer (HNC). We report the first use of KeraStat® Cream (KC), a topical, keratin-based wound dressing, in patients with HNC receiving RT.

Methods: This pilot study randomized HNC patients treated with definitive or postoperative RT (≥60 Gy) to KC or standard of care (SOC), applied at least twice daily during and for 1-month after RT. Outcomes of interest included adherence to the assigned regimen (at least 10 applications per week of treatment), clinician- and patient-reported RD, and skin-related quality of life.

Results: 24 patients were randomized and completed the study. Most patients had stage III-IV disease and oropharynx cancer. Median RT dose was 68 Gy; the bilateral neck was treated in 19 patients, and 18 patients received concurrent chemotherapy. Complete adherence was observed in 7/12 (SOC) vs. 10/12 (KC, p = 0.65). Adherence by patient-week was 61/68 versus 64/67, respectively (p = 0.20). No differences in RD were observed between groups.

Conclusion: A randomized trial of KC versus SOC in HNC patients treated with RT is feasible with good adherence to study agent. An adequately powered randomized study is warranted to test the efficacy of KC in reducing RD.

导言:放射性皮炎(RD)是头颈部癌症(HNC)放射治疗(RT)过程中经常出现的一种毒性反应。我们报告了首次在接受 RT 治疗的 HNC 患者中使用 KeraStat® Cream (KC)(一种基于角蛋白的局部伤口敷料)的情况:这项试验性研究将接受最终或术后 RT(≥60 Gy)治疗的 HNC 患者随机分配给 KC 或标准护理(SOC),在 RT 期间和 RT 后 1 个月内每天至少使用两次。研究结果包括对指定方案的依从性(每周至少涂抹 10 次)、临床医生和患者报告的 RD 以及与皮肤相关的生活质量。大多数患者都是口咽癌III-IV期患者。中位 RT 剂量为 68 Gy;19 名患者接受了双侧颈部治疗,18 名患者同时接受了化疗。7/12(SOC)对10/12(KC,P = 0.65)例患者完全坚持治疗。按患者周数计算的坚持率分别为 61/68 对 64/67(p = 0.20)。两组患者的 RD 无差异:结论:在接受 RT 治疗的 HNC 患者中进行 KC 与 SOC 的随机试验是可行的,且患者对研究药物的依从性良好。有必要进行充分有效的随机研究,以检验 KC 在降低 RD 方面的疗效。
{"title":"Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study.","authors":"Ryan T Hughes, Beverly J Levine, Bart A Frizzell, Kathryn M Greven, Mercedes Porosnicu, Thomas W Lycan, Luke R Burnett, Karen M Winkfield","doi":"10.1017/s1460396924000037","DOIUrl":"10.1017/s1460396924000037","url":null,"abstract":"<p><strong>Introduction: </strong>Radiation dermatitis (RD) is a frequent toxicity during radiotherapy (RT) for head and neck cancer (HNC). We report the first use of KeraStat<sup>®</sup> Cream (KC), a topical, keratin-based wound dressing, in patients with HNC receiving RT.</p><p><strong>Methods: </strong>This pilot study randomized HNC patients treated with definitive or postoperative RT (≥60 Gy) to KC or standard of care (SOC), applied at least twice daily during and for 1-month after RT. Outcomes of interest included adherence to the assigned regimen (at least 10 applications per week of treatment), clinician- and patient-reported RD, and skin-related quality of life.</p><p><strong>Results: </strong>24 patients were randomized and completed the study. Most patients had stage III-IV disease and oropharynx cancer. Median RT dose was 68 Gy; the bilateral neck was treated in 19 patients, and 18 patients received concurrent chemotherapy. Complete adherence was observed in 7/12 (SOC) vs. 10/12 (KC, <i>p</i> = 0.65). Adherence by patient-week was 61/68 versus 64/67, respectively (<i>p</i> = 0.20). No differences in RD were observed between groups.</p><p><strong>Conclusion: </strong>A randomized trial of KC versus SOC in HNC patients treated with RT is feasible with good adherence to study agent. An adequately powered randomized study is warranted to test the efficacy of KC in reducing RD.</p>","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single catheter 3d volume based hybrid inverse planning optimization in IVBT can improve organ sparing – CORRIGENDUM IVBT 中基于单导管三维容积的混合反向规划优化可改善器官疏通 - CORRIGENDUM
IF 0.4 Q4 Medicine Pub Date : 2023-11-30 DOI: 10.1017/S1460396923000419
B. K. Barik, J. Jena, Dillip Kumar Sahoo, Anupama Muraleedharan, Santosh Kumar Parida, Bikash Ranjan Mohapatra, S. Barik, D. Das, S. D. Das Majumdar, D. Parida
{"title":"Single catheter 3d volume based hybrid inverse planning optimization in IVBT can improve organ sparing – CORRIGENDUM","authors":"B. K. Barik, J. Jena, Dillip Kumar Sahoo, Anupama Muraleedharan, Santosh Kumar Parida, Bikash Ranjan Mohapatra, S. Barik, D. Das, S. D. Das Majumdar, D. Parida","doi":"10.1017/S1460396923000419","DOIUrl":"https://doi.org/10.1017/S1460396923000419","url":null,"abstract":"","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139206317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric case study of 3-D FiF vs. VMAT techniques in the treatment of H/N tumour 三维FiF与VMAT技术治疗H/N肿瘤的剂量分析
IF 0.4 Q4 Medicine Pub Date : 2023-08-25 DOI: 10.1017/S1460396923000304
Zhaohui Xie
Abstract A case study comparing three-dimensional conformal radiation therapy with field-in-field (FiF) technique and volumetric-modulated arc therapy (VMAT) for head/neck (H/N) irradiation, evaluating the differences in the treatment techniques and low doses to critical structures. Compared to VMAT plan, 3D FIF plan offers similar planning target volume coverage and acceptable organs at risk dose. Therefore, 3D FIF is still a feasible alternative for some centres unqualified for IMRT/VMAT worldwide.
摘要一项比较三维适形放射治疗与场中野(FiF)技术和体积调制电弧治疗(VMAT)头颈部(H/N)照射的病例研究,评估了治疗技术和低剂量对关键结构的差异。与VMAT计划相比,3D FIF计划提供了类似的计划目标体积覆盖范围和可接受的器官风险剂量。因此,对于世界范围内不符合IMRT/VMAT条件的一些中心来说,3D FIF仍然是一种可行的替代方案。
{"title":"Dosimetric case study of 3-D FiF vs. VMAT techniques in the treatment of H/N tumour","authors":"Zhaohui Xie","doi":"10.1017/S1460396923000304","DOIUrl":"https://doi.org/10.1017/S1460396923000304","url":null,"abstract":"Abstract A case study comparing three-dimensional conformal radiation therapy with field-in-field (FiF) technique and volumetric-modulated arc therapy (VMAT) for head/neck (H/N) irradiation, evaluating the differences in the treatment techniques and low doses to critical structures. Compared to VMAT plan, 3D FIF plan offers similar planning target volume coverage and acceptable organs at risk dose. Therefore, 3D FIF is still a feasible alternative for some centres unqualified for IMRT/VMAT worldwide.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48647242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic breast cancer to oesophagus: a case report and review of the literature 乳腺癌转移至食道:1例报告及文献回顾
IF 0.4 Q4 Medicine Pub Date : 2023-07-28 DOI: 10.1017/S1460396923000298
Bhuvana J, Akash Pandya, M. Mehta, S. U
Abstract Background: Secondary oesophageal carcinoma from a breast primary is an infrequent phenomenon. Given the rarity of this presentation, there is a general lack of consensus on management guidelines. Materials and methods: Herein, we report a case of a 65-year-old female presented with dysphagia, 14 years post-surgery for breast cancer. She was diagnosed with oesophageal metastases and was treated with combination of systemic chemotherapy, hormonal therapy and local radiotherapy. Our patient tolerated the treatment well and achieved a significant symptomatic improvement post-radiotherapy. We also performed a review of literature on oesophageal metastases from breast primary, aiming to improve the diagnostic accuracy and treatment efficacy in this rare presentation. Conclusions: We conclude that patients who present with persistent dysphagia post-breast cancer treatment should undergo an endoscopic ultrasound (EUS)-guided fine-needle biopsy (FNB) to rule out oesophageal metastasis. We suggest systemic chemotherapy with hormonal therapy and radiotherapy for local control as a management of choice in this condition. Even though prognosis is difficult to predict in these patients, this combined modality of treatment seems to achieve better overall survival.
背景:乳腺原发继发性食管癌是一种罕见的现象。考虑到这种演讲的罕见性,在管理指导方针上普遍缺乏共识。材料和方法:在此,我们报告一例65岁的女性在乳腺癌术后14年出现吞咽困难。她被诊断为食管转移,并接受全身化疗、激素治疗和局部放疗联合治疗。患者对治疗耐受良好,放疗后症状明显改善。我们也回顾了有关乳腺原发食管转移的文献,旨在提高这种罕见疾病的诊断准确性和治疗效果。结论:我们得出结论,乳腺癌治疗后出现持续吞咽困难的患者应接受内镜超声(EUS)引导下的细针活检(FNB)以排除食管转移。我们建议在这种情况下,全身化疗与激素治疗和局部控制放射治疗作为管理选择。尽管这些患者的预后难以预测,但这种联合治疗方式似乎可以获得更好的总生存率。
{"title":"Metastatic breast cancer to oesophagus: a case report and review of the literature","authors":"Bhuvana J, Akash Pandya, M. Mehta, S. U","doi":"10.1017/S1460396923000298","DOIUrl":"https://doi.org/10.1017/S1460396923000298","url":null,"abstract":"Abstract Background: Secondary oesophageal carcinoma from a breast primary is an infrequent phenomenon. Given the rarity of this presentation, there is a general lack of consensus on management guidelines. Materials and methods: Herein, we report a case of a 65-year-old female presented with dysphagia, 14 years post-surgery for breast cancer. She was diagnosed with oesophageal metastases and was treated with combination of systemic chemotherapy, hormonal therapy and local radiotherapy. Our patient tolerated the treatment well and achieved a significant symptomatic improvement post-radiotherapy. We also performed a review of literature on oesophageal metastases from breast primary, aiming to improve the diagnostic accuracy and treatment efficacy in this rare presentation. Conclusions: We conclude that patients who present with persistent dysphagia post-breast cancer treatment should undergo an endoscopic ultrasound (EUS)-guided fine-needle biopsy (FNB) to rule out oesophageal metastasis. We suggest systemic chemotherapy with hormonal therapy and radiotherapy for local control as a management of choice in this condition. Even though prognosis is difficult to predict in these patients, this combined modality of treatment seems to achieve better overall survival.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43949769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental determination of set-up displacements in anthropomorphic phantom in single-isocentre radiosurgery for multiple brain metastases by off-axis Winston–Lutz test: ExacTracTM v.6 versus DynamicTM 离轴Winston–Lutz试验测定多发性脑转移瘤单等中心放射外科手术中拟人体模的设置位移:ExacTracTM v.6与DynamicTM
IF 0.4 Q4 Medicine Pub Date : 2023-07-24 DOI: 10.1017/S1460396923000274
J. A. Rojas-López, M. Chesta, C. Venencia
Abstract Purpose: We compare the accuracy of the off-axis Winston–Lutz (WL) test in two versions of ExacTracTM: version 6.0 (ETv6) and Dynamic (ETD) in the same linac (TrueBeam STx®). Materials and methods: An upgraded of the ExacTracTM system was done in our institution. It was designed as an off-axis WL test before the update for comparison purposes. A head 3D-printed phantom based on a patient’s computed tomography images was used. Nine metallic fiducials were inserted and distributed on the phantom. Each target (fiducial) was designed an off-axis WL test with eight different gantry/collimator/table combinations. The phantom was placed using two different ETv6 and ETD in the same linac, and cone-beam computed tomography and electronic portal imaging device (EPID) images were acquired. The 2D deviation between the centre of the fiducial and the radiation field was found and compared with the original digital reconstructed radiography (DRR) by the profiles. Results: The phantom allows the definition of a procedure to determine off-axis deviations in radiosurgery treatments. The displacements calculated from the WL test showed acceptable values for both versions taking into account 3D displacement tolerances of 1 mm. These values were reached with rigorous quality assurance (QA) linac tests performed routinely that include mechanical, MV/kV and image-guided radiotherapy (IGRT) tests. However, ETD indicated more accurate values for all the targets no matter the distance to the isocentre (3D displacements < 0·5 mm). Conclusion: In terms of the IGRT correction without set-up displacements, ETD is up to twice as accurate as the ETv6, showing 3D displacements up to 0·5 mm in all targets.
摘要目的:我们比较了同一直线加速器(TrueBeam STx®)中两个版本的ExacTracTM的离轴Winston–Lutz(WL)测试的准确性:6.0版(ETv6)和Dynamic(ETD)。材料和方法:在我院对ExacTracTM系统进行了升级。它在更新前被设计为离轴WL测试,用于比较目的。使用基于患者计算机断层扫描图像的头部3D打印体模。九个金属基准被插入并分布在模型上。每个目标(基准)都设计了一个离轴WL测试,具有八种不同的龙门架/准直器/工作台组合。使用两种不同的ETv6和ETD将体模放置在同一直线加速器中,并获取锥束计算机断层扫描和电子门脉成像设备(EPID)图像。发现基准中心和辐射场之间的2D偏差,并通过剖面与原始数字重建射线照相术(DRR)进行比较。结果:该模型允许定义一个程序来确定放射外科治疗中的离轴偏差。考虑到1mm的3D位移公差,WL测试计算的位移显示出两种版本的可接受值。这些值是通过严格的质量保证(QA)直线加速器测试达到的,这些测试包括机械、MV/kV和图像引导放射治疗(IGRT)测试。然而,ETD表明,无论到等中心的距离如何,所有目标的值都更准确(3D位移<0.5 mm)。结论:在没有设置位移的IGRT校正方面,ETD的精度高达ETv6的两倍,在所有目标中显示高达0.5 mm的3D位移。
{"title":"Experimental determination of set-up displacements in anthropomorphic phantom in single-isocentre radiosurgery for multiple brain metastases by off-axis Winston–Lutz test: ExacTracTM v.6 versus DynamicTM","authors":"J. A. Rojas-López, M. Chesta, C. Venencia","doi":"10.1017/S1460396923000274","DOIUrl":"https://doi.org/10.1017/S1460396923000274","url":null,"abstract":"Abstract Purpose: We compare the accuracy of the off-axis Winston–Lutz (WL) test in two versions of ExacTracTM: version 6.0 (ETv6) and Dynamic (ETD) in the same linac (TrueBeam STx®). Materials and methods: An upgraded of the ExacTracTM system was done in our institution. It was designed as an off-axis WL test before the update for comparison purposes. A head 3D-printed phantom based on a patient’s computed tomography images was used. Nine metallic fiducials were inserted and distributed on the phantom. Each target (fiducial) was designed an off-axis WL test with eight different gantry/collimator/table combinations. The phantom was placed using two different ETv6 and ETD in the same linac, and cone-beam computed tomography and electronic portal imaging device (EPID) images were acquired. The 2D deviation between the centre of the fiducial and the radiation field was found and compared with the original digital reconstructed radiography (DRR) by the profiles. Results: The phantom allows the definition of a procedure to determine off-axis deviations in radiosurgery treatments. The displacements calculated from the WL test showed acceptable values for both versions taking into account 3D displacement tolerances of 1 mm. These values were reached with rigorous quality assurance (QA) linac tests performed routinely that include mechanical, MV/kV and image-guided radiotherapy (IGRT) tests. However, ETD indicated more accurate values for all the targets no matter the distance to the isocentre (3D displacements < 0·5 mm). Conclusion: In terms of the IGRT correction without set-up displacements, ETD is up to twice as accurate as the ETv6, showing 3D displacements up to 0·5 mm in all targets.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43439047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verification of dose distribution by different material properties in intraoral mold irradiation 口腔内霉菌照射中不同材料特性剂量分布的验证
IF 0.4 Q4 Medicine Pub Date : 2023-07-20 DOI: 10.1017/S1460396923000286
H. Fuse, Fumihiro Tomita, Kenji Yasue, Hideaki Ikoma, Shin Miyakawa, Norikazu Kori, T. Fujisaki, Y. Ishimori, M. Monma, T. Okumura, Y. Tamaki
Abstract Background: Brachytherapy is an effective local treatment for early-stage head and neck cancers. Mold irradiation is a method in which the source is placed in the oral cavity in sites where the soft tissue is thin and an irradiation source cannot be implanted. However, dose calculations based on TG-43 may be subject to uncertainty due to the heterogeneity of tissues and materials used for the irradiation of head and neck cancers. Materials and Methods: In this study, we investigated the basic physical properties of different materials and densities in the molds, retrospectively analysed patient plans and verified the doses of intraoral mold irradiation using a dose verification system with MC simulations specifically designed for brachytherapy, which was constructed independently. Results and Discussion: Dose–volume histograms were obtained with a treatment planning system (TG-43) and MC simulation and revealed a non-negligible difference in coverage of high-risk clinical target volume (HR-CTV) and organ at risk (OAR) between calculations using computed tomography values and those with density changes. The underdose was 10·6%, 3·7% and 5·6% for HR-CTV, gross tumour volume and OAR, respectively, relative to the treatment plan. The calculations based on the differences in the elemental composition and density changes in TG-43, a water-based calculation algorithm, resulted in clinically significant dose differences. The validation method was used only for the cases of complex small source therapy. Conclusion: The findings of this study can be applied to more complex cases with steeper density gradients, such as mold irradiation.
摘要背景:近距离治疗是早期头颈癌的一种有效的局部治疗方法。霉菌照射是一种将放射源放置在口腔中软组织较薄且无法植入放射源的部位的方法。然而,由于用于头颈癌照射的组织和材料的异质性,基于TG-43的剂量计算可能存在不确定性。材料和方法:在这项研究中,我们研究了模具中不同材料和密度的基本物理特性,回顾性分析了患者计划,并使用专门为近距离放射治疗设计的MC模拟剂量验证系统验证了口内模具照射的剂量,该系统是独立构建的。结果和讨论:使用治疗计划系统(TG-43)和MC模拟获得剂量-体积直方图,并显示使用计算机断层扫描值和密度变化的计算之间,高风险临床目标体积(HR-CTV)和危险器官(OAR)的覆盖率存在不可忽略的差异。相对于治疗计划,HR-CTV、肿瘤总体积和OAR的欠剂量分别为10.6%、3.7%和5.6%。基于TG-43(一种基于水的计算算法)中元素组成和密度变化的差异进行的计算导致了临床上显著的剂量差异。该验证方法仅用于复杂小来源治疗的病例。结论:本研究结果可应用于密度梯度更陡的更复杂病例,如霉菌照射。
{"title":"Verification of dose distribution by different material properties in intraoral mold irradiation","authors":"H. Fuse, Fumihiro Tomita, Kenji Yasue, Hideaki Ikoma, Shin Miyakawa, Norikazu Kori, T. Fujisaki, Y. Ishimori, M. Monma, T. Okumura, Y. Tamaki","doi":"10.1017/S1460396923000286","DOIUrl":"https://doi.org/10.1017/S1460396923000286","url":null,"abstract":"Abstract Background: Brachytherapy is an effective local treatment for early-stage head and neck cancers. Mold irradiation is a method in which the source is placed in the oral cavity in sites where the soft tissue is thin and an irradiation source cannot be implanted. However, dose calculations based on TG-43 may be subject to uncertainty due to the heterogeneity of tissues and materials used for the irradiation of head and neck cancers. Materials and Methods: In this study, we investigated the basic physical properties of different materials and densities in the molds, retrospectively analysed patient plans and verified the doses of intraoral mold irradiation using a dose verification system with MC simulations specifically designed for brachytherapy, which was constructed independently. Results and Discussion: Dose–volume histograms were obtained with a treatment planning system (TG-43) and MC simulation and revealed a non-negligible difference in coverage of high-risk clinical target volume (HR-CTV) and organ at risk (OAR) between calculations using computed tomography values and those with density changes. The underdose was 10·6%, 3·7% and 5·6% for HR-CTV, gross tumour volume and OAR, respectively, relative to the treatment plan. The calculations based on the differences in the elemental composition and density changes in TG-43, a water-based calculation algorithm, resulted in clinically significant dose differences. The validation method was used only for the cases of complex small source therapy. Conclusion: The findings of this study can be applied to more complex cases with steeper density gradients, such as mold irradiation.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45816907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single- and dual-source-strength focal boost planning in low-dose-rate prostate brachytherapy: feasibility study 低剂量率前列腺近距离放射治疗的单、双源聚焦增强计划:可行性研究
IF 0.4 Q4 Medicine Pub Date : 2023-07-03 DOI: 10.1017/S1460396923000225
A. Clark, G. Wright, J. Mason, O. Hulson, A. Henry, S. Rodda, P. Bownes
Abstract Introduction: This study investigates the dose escalation to dominant intra-prostatic lesions (DILs) that is achievable using single-source-strength (SSS) and dual-source-strength (DSS) low-dose-rate (LDR) prostate brachytherapy and a sector-based plan approach. Methods: Twenty patients were retrospectively analysed. Image registration and planning were undertaken using VariSeed v9·0. SSS and DSS boost plans were produced and compared to clinical plans. Dosimetric robustness to seed displacement for SSS and DSS plans was compared to clinical plans using Monte Carlo simulations. Results: Fourteen out of 20 patients had DIL identifiable on magnetic resonance imaging. Median increase in sector D90 of 27% (p < 0·0001) and sector V150 of 31% (p < 0·0001) was achieved with SSS planning without exceeding local rectum and urethra dose constraints. DSS plans achieved dose distributions not statistically significantly different from the SSS plans with a median of eight fewer seeds and two fewer needles. SSS and DSS plan sensitivity to random seed displacement was similar to the clinical plans. Conclusions: Treatment planning using VariSeed to produce SSS and DSS focal boost plans is feasible for LDR prostate brachytherapy to achieve a median escalation in sector D90 of 27% without exceeding local urethral and rectal constraints. SSS and DSS plan dosimetric robustness was similar to clinical plan dosimetric robustness.
摘要:本研究探讨了单源强度(SSS)和双源强度(DSS)低剂量率(LDR)前列腺近距离治疗和基于部门的计划方法对显性前列腺内病变(DILs)的剂量递增。方法:对20例患者进行回顾性分析。使用VariSeed v9·0进行图像配准和规划。制作SSS和DSS提升计划,并与临床计划进行比较。使用蒙特卡罗模拟比较了SSS和DSS计划与临床计划的剂量学对种子位移的鲁棒性。结果:20例患者中有14例在磁共振成像上可识别DIL。SSS计划在不超过局部直肠和尿道剂量限制的情况下,D90区中位增加27% (p < 0.0001), V150区中位增加31% (p < 0.0001)。DSS计划获得的剂量分布与SSS计划无统计学显著差异,中位数为少8粒种子和少2针。SSS和DSS计划对随机种子移位的敏感性与临床计划相似。结论:使用VariSeed制作SSS和DSS局部增强计划的治疗计划对于LDR前列腺近距离治疗是可行的,在不超过局部尿道和直肠约束的情况下,D90区中位上升27%。SSS和DSS计划剂量学稳健性与临床计划剂量学稳健性相似。
{"title":"Single- and dual-source-strength focal boost planning in low-dose-rate prostate brachytherapy: feasibility study","authors":"A. Clark, G. Wright, J. Mason, O. Hulson, A. Henry, S. Rodda, P. Bownes","doi":"10.1017/S1460396923000225","DOIUrl":"https://doi.org/10.1017/S1460396923000225","url":null,"abstract":"Abstract Introduction: This study investigates the dose escalation to dominant intra-prostatic lesions (DILs) that is achievable using single-source-strength (SSS) and dual-source-strength (DSS) low-dose-rate (LDR) prostate brachytherapy and a sector-based plan approach. Methods: Twenty patients were retrospectively analysed. Image registration and planning were undertaken using VariSeed v9·0. SSS and DSS boost plans were produced and compared to clinical plans. Dosimetric robustness to seed displacement for SSS and DSS plans was compared to clinical plans using Monte Carlo simulations. Results: Fourteen out of 20 patients had DIL identifiable on magnetic resonance imaging. Median increase in sector D90 of 27% (p < 0·0001) and sector V150 of 31% (p < 0·0001) was achieved with SSS planning without exceeding local rectum and urethra dose constraints. DSS plans achieved dose distributions not statistically significantly different from the SSS plans with a median of eight fewer seeds and two fewer needles. SSS and DSS plan sensitivity to random seed displacement was similar to the clinical plans. Conclusions: Treatment planning using VariSeed to produce SSS and DSS focal boost plans is feasible for LDR prostate brachytherapy to achieve a median escalation in sector D90 of 27% without exceeding local urethral and rectal constraints. SSS and DSS plan dosimetric robustness was similar to clinical plan dosimetric robustness.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47393562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric comparison of three-dimensional (3D), intensity-modulated radiotherapy (IMRT) and hybrid IMRT for left-sided postmastectomy radiation therapy (PMRT) 三维(3D)、调强放射治疗(IMRT)和混合IMRT用于左侧切除术后放射治疗(PMRT)的剂量比较
IF 0.4 Q4 Medicine Pub Date : 2023-06-29 DOI: 10.1017/S1460396923000250
Siwika Thongthanom, W. Nobnop
Abstract Purpose: This study aimed to determine the suitable breast treatment technique for a small facility’s hospital with limited staff and equipment resources. The benefits and drawbacks of each technique should be considered to guide radiation oncologists choose the appropriate treatment option for postmastectomy radiation therapy (PMRT) patients. Methods and Materials: This study included the computed tomography images of 15 patients who received left-sided PMRT. The patient’s characteristics were classified into two groups: 1. irradiation of only the chest wall (CW) and 2. CW lymph nodes plus supraclavicular lymph nodes (SPCs). All 15 PMRT patients were generated in 4 treatment techniques including 3DCRT, field-in-field (FiF), intensity-modulated radiotherapy (IMRT) and hybrid (3DCRT + IMRT). Each treatment technique’s dosimetric parameters and treatment time were compared. Result: All four treatment plans met the acceptable criteria. The IMRT plans achieved the highest plan quality scores for two groups of PMRT patients but require the longest treatment time, whereas the 3DCRT and FiF plans demonstrated superiority for organ at risk (OAR) sparing and required the shortest treatment time when compared with the IMRT and hybrid plans. Conclusion: The IMRT plan had the highest plan quality but required the most time to treat. Treatment times are critical in facilities with limited resources. As a result, the FiF plan was found to be a suitable technique for both CW-only and CW plus SPC irradiation due to its short treatment time and high plan quality scores for OAR dose sparing.
摘要目的:本研究旨在为一家人员和设备资源有限的小型医院确定合适的乳腺治疗技术。应考虑每种技术的优缺点,以指导放射肿瘤学家为骨切除术后放射治疗(PMRT)患者选择合适的治疗方案。方法和材料:本研究包括15例接受左侧PMRT的患者的计算机断层扫描图像。患者的特征分为两组:1。仅照射胸壁(CW)和2。CW淋巴结加锁骨上淋巴结(SPC)。所有15例PMRT患者均采用3DCRT、场中放疗(FiF)、调强放疗(IMRT)和混合放疗(3DCRT+IMRT)4种治疗技术。比较了每种治疗技术的剂量测定参数和治疗时间。结果:四个治疗方案均符合可接受标准。IMRT计划在两组PMRT患者中获得了最高的计划质量分数,但需要最长的治疗时间,而3DCRT和FiF计划在保留器官风险(OAR)方面表现出优势,与IMRT和混合计划相比,需要最短的治疗时间。结论:IMRT方案具有最高的方案质量,但需要最多的治疗时间。在资源有限的设施中,治疗时间至关重要。因此,FiF计划被发现是一种适用于仅CW和CW加SPC照射的技术,因为其治疗时间短,且OAR剂量节省的计划质量分数高。
{"title":"Dosimetric comparison of three-dimensional (3D), intensity-modulated radiotherapy (IMRT) and hybrid IMRT for left-sided postmastectomy radiation therapy (PMRT)","authors":"Siwika Thongthanom, W. Nobnop","doi":"10.1017/S1460396923000250","DOIUrl":"https://doi.org/10.1017/S1460396923000250","url":null,"abstract":"Abstract Purpose: This study aimed to determine the suitable breast treatment technique for a small facility’s hospital with limited staff and equipment resources. The benefits and drawbacks of each technique should be considered to guide radiation oncologists choose the appropriate treatment option for postmastectomy radiation therapy (PMRT) patients. Methods and Materials: This study included the computed tomography images of 15 patients who received left-sided PMRT. The patient’s characteristics were classified into two groups: 1. irradiation of only the chest wall (CW) and 2. CW lymph nodes plus supraclavicular lymph nodes (SPCs). All 15 PMRT patients were generated in 4 treatment techniques including 3DCRT, field-in-field (FiF), intensity-modulated radiotherapy (IMRT) and hybrid (3DCRT + IMRT). Each treatment technique’s dosimetric parameters and treatment time were compared. Result: All four treatment plans met the acceptable criteria. The IMRT plans achieved the highest plan quality scores for two groups of PMRT patients but require the longest treatment time, whereas the 3DCRT and FiF plans demonstrated superiority for organ at risk (OAR) sparing and required the shortest treatment time when compared with the IMRT and hybrid plans. Conclusion: The IMRT plan had the highest plan quality but required the most time to treat. Treatment times are critical in facilities with limited resources. As a result, the FiF plan was found to be a suitable technique for both CW-only and CW plus SPC irradiation due to its short treatment time and high plan quality scores for OAR dose sparing.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45819063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Radiotherapy in Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1